Canopy Growth (CGC) Financials: History & Chart

Canopy Growth Corporation(CGC)

Drug Manufacturers - Specialty & Generic · Smiths Falls, ON

$0.89+0.00 (+0.12%)

Delayed quote: Oct 6, 2026, 12:15 PM EDT

About Canopy Growth Corporation

Canopy Growth Corporation (CGC), alongside its affiliated businesses, specializes in the cultivation, marketing, and retail of both cannabis and hemp-derived products. These offerings are designed for both recreational consumption and therapeutic uses, with its primary commercial reach extending across Canada, the United States, and Germany. The company structures its operations into two main divisions: Global Cannabis and a diverse portfolio of Other Consumer Products. Its extensive product range features dried cannabis flower, various extracts and concentrates, infused beverages, edible gummies, and vape cartridges. Canopy Growth distributes these items under numerous well-known brands, such as Tweed, 7ACRES, Martha Stewart CBD, and Spectrum Therapeutics, among others. Originally founded as Tweed Marijuana Inc., the enterprise adopted its current name, Canopy Growth Corporation, in September 2015. Established in 2009, the firm maintains its corporate headquarters in Smiths Falls, Canada.

Smiths Falls, ON

1,128 employees

www.canopygrowth.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Luc Mongeau

View full financials

Financials

SEC Filings

Quarterly Income Statement (USD)

Swipe horizontally to review earlier periods. The line-item column stays pinned.

Quarterly Report	TTM	Quarter ended Jun 2026	Quarter ended Mar 2026	Quarter ended Dec 2025	Quarter ended Sep 2025	Quarter ended Jun 2025	Quarter ended Mar 2025	Quarter ended Dec 2024	Quarter ended Sep 2024
Revenue	230.72M	57.14M	51.22M	74.48M	47.88M	52.98M	45.19M	51.95M	46.55M
Cost of Goods Sold	171.95M	41.48M	45.28M	53.03M	32.15M	39.73M	37.86M	35.21M	30.41M
Gross Profit	58.77M	15.66M	5.94M	21.45M	15.73M	13.25M	7.33M	16.75M	16.14M
Gross Profit Margin	25.5%	27.4%	11.6%	28.8%	32.8%	25.0%	16.2%	32.2%	34.7%
Total Operating Expenses	132.55M	31.22M	25.69M	47.78M	27.86M	29.87M	10.38M	33.30M	50.09M
Research & Development	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Selling, General & Administrative	103.13M	28.32M	22.41M	29.76M	22.65M	22.35M	6.12M	26.12M	27.35M
Operating Income (EBIT)	-73.78M	-15.57M	-19.75M	-26.33M	-12.13M	-16.62M	-3.05M	-16.55M	-33.95M
Operating Margin	-32.0%	-27.2%	-38.6%	-35.3%	-25.3%	-31.4%	-6.7%	-31.9%	-72.9%
Income Before Tax (EBT)	-187.15M	-10.35M	-113.56M	-62.21M	-1.02M	-30.29M	-153.68M	-84.49M	-97.00M
Interest Income	9.57M	2.28M	2.78M	3.10M	1.42M	776K	1.67M	1.35M	1.79M
Interest Expense	31.43M	8.92M	8.85M	7.33M	6.32M	7.15M	10.69M	11.65M	15.73M
Other Income/Expense	-113.37M	5.21M	-93.81M	-35.88M	11.11M	-13.67M	-150.63M	-67.93M	-63.04M
Net Income	-186.97M	-10.26M	-112.95M	-62.58M	-1.18M	-30.50M	-153.41M	-84.71M	-94.81M
Income Tax Expense	-181K	-91K	-611K	368K	154K	214K	229K	220K	223K
Net Profit Margin	-81.0%	-18.0%	-220.5%	-84.0%	-2.5%	-57.6%	-339.5%	-163.0%	-203.7%
EBITDA	-44.96M	-8.50M	-13.53M	-17.43M	-5.49M	-9.51M	4.92M	-9.39M	-26.34M
EBITDA Margin	-19.5%	-14.9%	-26.4%	-23.4%	-11.5%	-18.0%	10.9%	-18.1%	-56.6%
Depreciation & Amortization	28.82M	7.06M	6.22M	8.90M	6.64M	7.10M	7.97M	7.17M	7.62M
EPS Basic	-0.50	-0.02	-0.29	-0.18	-0.00	-0.16	N/A	-0.77	-1.09
EPS Diluted	-0.50	-0.02	-0.29	-0.18	-0.00	-0.16	N/A	-0.77	-1.09
Weighted Average Basic Shares	422.26M	422.26M	384.99M	345.53M	274.03M	188.32M	107.55M	110.31M	86.83M
Weighted Average Diluted Shares	422.26M	422.26M	384.99M	345.53M	274.03M	188.32M	107.55M	110.31M	86.83M

Annual Income Statement (USD)

Swipe horizontally to review earlier years. The line-item column stays pinned.

Annual Report	03/31/2026	03/31/2025	03/31/2024	03/31/2023	03/31/2022	03/31/2021	03/31/2020	03/31/2019
Revenue	204.61M	186.91M	219.75M	246.41M	380.18M	435.04M	283.36M	169.58M
Cost of Goods Sold	154.52M	131.66M	159.94M	293.38M	529.96M	381.75M	305.87M	102.95M
Gross Profit	50.09M	55.25M	59.82M	-46.97M	-149.78M	53.29M	-22.51M	66.63M
Gross Profit Margin	24.5%	29.6%	27.2%	-19.1%	-39.4%	12.2%	-7.9%	39.3%
Total Operating Expenses	102.64M	136.64M	228.96M	1.90B	664.44M	1.04B	1.16B	481.44M
Research & Development	N/A	N/A	3.41M	16.06M	25.78M	45.83M	43.92M	11.42M
Selling, General & Administrative	88.37M	84.57M	133.55M	220.32M	288.59M	416.89M	616.59M	453.90M
Operating Income (EBIT)	-52.56M	-81.40M	-169.14M	-1.95B	-814.22M	-989.58M	-1.19B	-460.93M
Operating Margin	-25.7%	-43.5%	-77.0%	-789.3%	-214.2%	-227.5%	-418.5%	-271.8%
Income Before Tax (EBT)	-188.99M	-414.82M	-348.59M	-2.28B	-214.07M	-1.34B	-1.07B	-531.38M
Interest Income	7.19M	6.13M	12.01M	17.95M	5.28M	17.00M	47.13M	36.95M
Interest Expense	27.46M	51.81M	77.91M	93.28M	83.07M	6.73M	4.77M	13.80M
Other Income/Expense	-136.44M	-333.42M	-179.44M	-336.90M	600.15M	-350.57M	113.63M	-70.45M
Net Income	-189.01M	-415.59M	-486.08M	-2.42B	-247.79M	-1.39B	-938.89M	-551.64M
Income Tax Expense	17K	4.96M	9.12M	-4.24M	-7.15M	-10.46M	-86.42M	3.08M
Net Profit Margin	-92.4%	-222.4%	-221.2%	-983.7%	-65.2%	-319.2%	-331.3%	-325.3%
EBITDA	-26.34M	-51.44M	-129.82M	-1.89B	-725.56M	-888.42M	-1.10B	-425.78M
EBITDA Margin	-12.9%	-27.5%	-59.1%	-765.3%	-190.8%	-204.2%	-387.2%	-251.1%
Depreciation & Amortization	26.22M	29.96M	39.33M	59.18M	88.66M	101.16M	88.83M	35.15M
EPS Basic	N/A	-3.84	-6.50	-52.28	-6.15	-3.54	-2.81	-1.49
EPS Diluted	N/A	-3.84	-6.50	-52.28	-6.15	-3.54	-2.77	-1.49
Weighted Average Basic Shares	2.98B	107.55M	74.79M	46.37M	39.13M	375.28M	350.03M	337.51M
Weighted Average Diluted Shares	2.98B	107.55M	74.79M	46.37M	39.13M	375.71M	356.15M	337.51M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.